These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17631918)

  • 1. Different effects of ionotropic and metabotropic glutamate receptor antagonists on attention and the attentional properties of nicotine.
    Quarta D; Naylor CG; Morris HV; Patel S; Genn RF; Stolerman IP
    Neuropharmacology; 2007 Sep; 53(3):421-30. PubMed ID: 17631918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sertindole restores attentional performance and suppresses glutamate release induced by the NMDA receptor antagonist CPP.
    Carli M; Calcagno E; Mainini E; Arnt J; Invernizzi RW
    Psychopharmacology (Berl); 2011 Apr; 214(3):625-37. PubMed ID: 21049266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats.
    Carli M; Baviera M; Invernizzi RW; Balducci C
    Neuropsychopharmacology; 2006 Apr; 31(4):757-67. PubMed ID: 16192987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serotonin 5-HT2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex.
    Mirjana C; Baviera M; Invernizzi RW; Balducci C
    Neuropsychopharmacology; 2004 Sep; 29(9):1637-47. PubMed ID: 15127084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic nicotine and dizocilpine effects on nicotinic and NMDA glutamatergic receptor regulation: interactions with clozapine actions and attentional performance in rats.
    Rezvani AH; Tizabi Y; Getachew B; Hauser SR; Caldwell DP; Hunter C; Levin ED
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1030-40. PubMed ID: 18343006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.
    Liechti ME; Markou A
    Eur J Pharmacol; 2007 Jan; 554(2-3):164-74. PubMed ID: 17113075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) microinfusions into the nucleus accumbens shell or ventral tegmental area attenuate the reinforcing effects of nicotine in rats.
    D'Souza MS; Markou A
    Neuropharmacology; 2011 Dec; 61(8):1399-405. PubMed ID: 21896278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinic-glutamatergic interactions and attentional performance on an operant visual signal detection task in female rats.
    Rezvani AH; Levin ED
    Eur J Pharmacol; 2003 Mar; 465(1-2):83-90. PubMed ID: 12650836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dopamine receptor antagonists on nicotine-induced attentional enhancement.
    Hahn B; Shoaib M; Stolerman IP
    Behav Pharmacol; 2002 Dec; 13(8):621-32. PubMed ID: 12478212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin antagonists in the five-choice serial reaction time task and their interactions with nicotine.
    Quarta D; Naylor CG; Glennon JC; Stolerman IP
    Behav Pharmacol; 2012 Apr; 23(2):143-52. PubMed ID: 22193593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of the mGluR5 antagonist MPEP and the mGluR2/3 antagonist LY341495 on rats' performance in the 5-choice serial reaction time task.
    Semenova S; Markou A
    Neuropharmacology; 2007 Mar; 52(3):863-72. PubMed ID: 17126859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism at metabotropic glutamate 5 receptors inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking.
    Tessari M; Pilla M; Andreoli M; Hutcheson DM; Heidbreder CA
    Eur J Pharmacol; 2004 Sep; 499(1-2):121-33. PubMed ID: 15363959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective nicotinic receptor antagonists: effects on attention and nicotine-induced attentional enhancement.
    Hahn B; Shoaib M; Stolerman IP
    Psychopharmacology (Berl); 2011 Sep; 217(1):75-82. PubMed ID: 21432025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic interaction of dopamine D₁ and glutamate N-methyl-D-aspartate receptors in the rat dorsal striatum controls attention.
    Agnoli L; Carli M
    Neuroscience; 2011 Jun; 185():39-49. PubMed ID: 21536111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
    Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
    Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats.
    Kenny PJ; Gasparini F; Markou A
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1068-76. PubMed ID: 12805481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention deficit induced by blockade of N-methyl D-aspartate receptors in the prefrontal cortex is associated with enhanced glutamate release and cAMP response element binding protein phosphorylation: role of metabotropic glutamate receptors 2/3.
    Pozzi L; Baviera M; Sacchetti G; Calcagno E; Balducci C; Invernizzi RW; Carli M
    Neuroscience; 2011 Mar; 176():336-48. PubMed ID: 21193020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice.
    Paterson NE; Semenova S; Gasparini F; Markou A
    Psychopharmacology (Berl); 2003 May; 167(3):257-64. PubMed ID: 12682710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of aripiprazole, olanzapine, and haloperidol in a model of cognitive deficit of schizophrenia in rats: relationship with glutamate release in the medial prefrontal cortex.
    Carli M; Calcagno E; Mainolfi P; Mainini E; Invernizzi RW
    Psychopharmacology (Berl); 2011 Apr; 214(3):639-52. PubMed ID: 21052982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol and clozapine have dissociable effects in a model of attentional performance deficits induced by blockade of NMDA receptors in the mPFC.
    Baviera M; Invernizzi RW; Carli M
    Psychopharmacology (Berl); 2008 Feb; 196(2):269-80. PubMed ID: 17940750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.